ArticleIn vivo (Athens, Greece)

Risk Factors and Clinical Significance of Grade ≥3 Neutropenia During the First Cycle of Cabazitaxel Therapy With Primary Pegfilgrastim Prophylaxis in Metastatic Castration-resistant Prostate Cancer.

Ryo Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.